GIM
WST icon

Granahan Investment Management’s West Pharmaceutical WST Stock Holding History

Granahan Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,609
Closed -$2.83M – 205
2020
Q1 		$2.83M Sell
18,609
-13,890
-43% -$2.14M 0.15% 114
2019
Q4 		$4.89M Sell
32,499
-5,510
-14% -$802K 0.22% 92
2019
Q3 		$5.39M Sell
38,009
-9,710
-20% -$1.34M 0.3% 82
2019
Q2 		$5.97M Sell
47,719
-12,881
-21% -$1.52M 0.3% 80
2019
Q1 		$6.68M Buy
60,600
+20,800
+52% +$2.16M 0.36% 72
2018
Q4 		$3.9M Buy
39,800
+5,600
+16% +$608K 0.28% 92
2018
Q3 		$4.22M Hold
34,200
– – 0.23% 110
2018
Q2 		$3.4M Hold
34,200
– – 0.2% 123
2018
Q1 		$3.02M Sell
34,200
-3,047
-8% -$285K 0.22% 125
2017
Q4 		$3.67M Hold
37,247
– – 0.29% 107
2017
Q3 		$3.58M Sell
37,247
-14
-0% -$1.27K 0.3% 108
2017
Q2 		$3.52M Buy
37,261
+3,032
+9% +$279K 0.32% 100
2017
Q1 		$2.79M Sell
34,229
-318,881
-90% -$26.7M 0.28% 107
2016
Q4 		$30M Hold
353,110
– – 1.03% 29
2016
Q3 		$26.3M Sell
353,110
-79,100
-18% -$6.28M 0.86% 32
2016
Q2 		$32.8M Sell
432,210
-109,200
-20% -$7.95M 1.2% 14
2016
Q1 		$37.5M Hold
541,410
– – 1.36% 11
2015
Q4 		$32.6M Sell
541,410
-122,990
-19% -$7.4M 1.12% 17
2015
Q3 		$36M Sell
664,400
-10,100
-1% -$589K 1.11% 12
2015
Q2 		$39.2M Hold
674,500
– – 1.11% 18
2015
Q1 		$40.6M Sell
674,500
-53,600
-7% -$2.86M 1.16% 15
2014
Q4 		$38.8M Sell
728,100
-555,700
-43% -$27.8M 1.13% 20
2014
Q3 		$57.5M Sell
1,283,800
-100,000
-7% -$4.25M 1.77% 1
2014
Q2 		$58.4M Sell
1,383,800
-305,900
-18% -$13.1M 1.7% 2
2014
Q1 		$74.4M Buy
1,689,700
+19,400
+1% +$913K 2.01% 1
2013
Q4 		$81.9M Hold
1,670,300
– – 2.11% 2
2013
Q3 		$68.7M Buy
1,670,300
+46,200
+3% +$1.76M 1.83% 2
2013
Q2 		$57.1M Buy
+1,624,100
New +$53.4M 1.64% 3

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Granahan Investment Management's WST Position: Q2 2020 in Review

Granahan Investment Management sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 18,609 shares — an estimated $2.83M sold.

Granahan Investment Management first reported a position in WST in Q2 2013 and held it in 28 quarters. The position peaked at $81.9M in Q4 2013. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Granahan Investment Management reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Granahan Investment Management sold 18,609 West Pharmaceutical shares in Q2 2020, an estimated $2.83M.
  • Granahan Investment Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 28 quarters.
  • Granahan Investment Management's West Pharmaceutical position peaked at $81.9M in Q4 2013.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.